Reduced sympathetic activity is associated with the development of pain and muscle atrophy in a female rat model of fibromyalgia
•Plasma epinephrine is decreased in priming models of fibromyalgia-like pain.•Clenbuterol attenuates hyperalgesia in an acid saline-induced fibromyalgia-like pain model.•Clenbuterol mitigates muscle atrophy in fibromyalgia priming model. Fibromyalgia (FM) is characterized by chronic widespread muscu...
Gespeichert in:
Veröffentlicht in: | Physiology & behavior 2024-07, Vol.281, p.114575-114575, Article 114575 |
---|---|
Hauptverfasser: | , , , , , , , , , , , , , , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
container_end_page | 114575 |
---|---|
container_issue | |
container_start_page | 114575 |
container_title | Physiology & behavior |
container_volume | 281 |
creator | da Silva, Raquel Prado Costa, Daniely Messias da Cruz-Filho, João Santos, Tatiane de Oliveira dos Anjos-Santos, Hevely Catharine Vasconcelos, Alan Bruno Silva Heck, Lilian Carmo Kettelhut, Ísis do Carmo Navegantes, Luiz Carlos dos Santos, José Ronaldo de Souza, Patrícia Rodrigues Marques Badauê-Passos Jr, Daniel Mecawi, André Souza DeSantana, Josimari Melo Lustrino, Danilo |
description | •Plasma epinephrine is decreased in priming models of fibromyalgia-like pain.•Clenbuterol attenuates hyperalgesia in an acid saline-induced fibromyalgia-like pain model.•Clenbuterol mitigates muscle atrophy in fibromyalgia priming model.
Fibromyalgia (FM) is characterized by chronic widespread musculoskeletal pain accompanied by fatigue and muscle atrophy. Although its etiology is not known, studies have shown that FM patients exhibit altered function of the sympathetic nervous system (SNS), which regulates nociception and muscle plasticity. Nevertheless, the precise SNS-mediated mechanisms governing hyperalgesia and skeletal muscle atrophy in FM remain unclear. Thus, we employed two distinct FM-like pain models, involving intramuscular injections of acidic saline (pH 4.0) or carrageenan in prepubertal female rats, and evaluated the catecholamine content, adrenergic signaling and overall muscle proteolysis. Subsequently, we assessed the contribution of the SNS to the development of hyperalgesia and muscle atrophy in acidic saline-injected rats treated with clenbuterol (a selective β2-adrenergic receptor agonist) and in animals maintained under baseline conditions and subjected to epinephrine depletion through adrenodemedullation (ADM). Seven days after inducing an FM-like model with acidic saline or carrageenan, we observed widespread mechanical hyperalgesia along with loss of strength and/or muscle mass. These changes were associated with reduced catecholamine content, suggesting a common underlying mechanism. Notably, treatment with a β2-agonist alleviated hyperalgesia and prevented muscle atrophy in acidic saline-induced FM-like pain, while epinephrine depletion induced mechanical hyperalgesia and increased muscle proteolysis in animals under baseline conditions. Together, the results suggest that reduced sympathetic activity is involved in the development of pain and muscle atrophy in the murine model of FM analyzed. |
doi_str_mv | 10.1016/j.physbeh.2024.114575 |
format | Article |
fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_3050172768</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S0031938424001203</els_id><sourcerecordid>3050172768</sourcerecordid><originalsourceid>FETCH-LOGICAL-c313t-f51e9de8b39f3d18366e486ed0ab8773ba49a13576405d2a678592136824d44e3</originalsourceid><addsrcrecordid>eNqFkE2v1CAUhonReMerP0HD0k1HKFDoypib60dyExOjiTtC4dRhUkoFOqY7f7pMZnQrG5I3z8s5PAi9pGRPCe3eHPfLYcsDHPYtafmeUi6keIR2VEnWCCK_P0Y7Qhhteqb4DXqW85HUwzh7im6Y6vq25jv0-wu41YLDeQuLKQco3mJjiz_5smGfsck5Wm9KRX75csAVwQ5OMMUlwFxwHPFi_IzN7HBYs50Am5JiXQ6fUzxCMDVLpuAQHUznwuiHFMNmph_ePEdPRjNleHG9b9G39_df7z42D58_fLp799BYRllpRkGhd6AG1o_MUcW6DrjqwBEzKCnZYHhvKBOy40S41nRSib6lrFMtd5wDu0WvL-8uKf5cIRcdfLYwTWaGuGbNiCBUtrJTFRUX1KaYc4JRL8kHkzZNiT7L10d9la_P8vVFfu29uo5YhwDuX-uv7Qq8vQBQP3rykHS2Huaq3yewRbvo_zPiD5qWmbI</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>3050172768</pqid></control><display><type>article</type><title>Reduced sympathetic activity is associated with the development of pain and muscle atrophy in a female rat model of fibromyalgia</title><source>MEDLINE</source><source>Elsevier ScienceDirect Journals</source><creator>da Silva, Raquel Prado ; Costa, Daniely Messias ; da Cruz-Filho, João ; Santos, Tatiane de Oliveira ; dos Anjos-Santos, Hevely Catharine ; Vasconcelos, Alan Bruno Silva ; Heck, Lilian Carmo ; Kettelhut, Ísis do Carmo ; Navegantes, Luiz Carlos ; dos Santos, José Ronaldo ; de Souza, Patrícia Rodrigues Marques ; Badauê-Passos Jr, Daniel ; Mecawi, André Souza ; DeSantana, Josimari Melo ; Lustrino, Danilo</creator><creatorcontrib>da Silva, Raquel Prado ; Costa, Daniely Messias ; da Cruz-Filho, João ; Santos, Tatiane de Oliveira ; dos Anjos-Santos, Hevely Catharine ; Vasconcelos, Alan Bruno Silva ; Heck, Lilian Carmo ; Kettelhut, Ísis do Carmo ; Navegantes, Luiz Carlos ; dos Santos, José Ronaldo ; de Souza, Patrícia Rodrigues Marques ; Badauê-Passos Jr, Daniel ; Mecawi, André Souza ; DeSantana, Josimari Melo ; Lustrino, Danilo</creatorcontrib><description>•Plasma epinephrine is decreased in priming models of fibromyalgia-like pain.•Clenbuterol attenuates hyperalgesia in an acid saline-induced fibromyalgia-like pain model.•Clenbuterol mitigates muscle atrophy in fibromyalgia priming model.
Fibromyalgia (FM) is characterized by chronic widespread musculoskeletal pain accompanied by fatigue and muscle atrophy. Although its etiology is not known, studies have shown that FM patients exhibit altered function of the sympathetic nervous system (SNS), which regulates nociception and muscle plasticity. Nevertheless, the precise SNS-mediated mechanisms governing hyperalgesia and skeletal muscle atrophy in FM remain unclear. Thus, we employed two distinct FM-like pain models, involving intramuscular injections of acidic saline (pH 4.0) or carrageenan in prepubertal female rats, and evaluated the catecholamine content, adrenergic signaling and overall muscle proteolysis. Subsequently, we assessed the contribution of the SNS to the development of hyperalgesia and muscle atrophy in acidic saline-injected rats treated with clenbuterol (a selective β2-adrenergic receptor agonist) and in animals maintained under baseline conditions and subjected to epinephrine depletion through adrenodemedullation (ADM). Seven days after inducing an FM-like model with acidic saline or carrageenan, we observed widespread mechanical hyperalgesia along with loss of strength and/or muscle mass. These changes were associated with reduced catecholamine content, suggesting a common underlying mechanism. Notably, treatment with a β2-agonist alleviated hyperalgesia and prevented muscle atrophy in acidic saline-induced FM-like pain, while epinephrine depletion induced mechanical hyperalgesia and increased muscle proteolysis in animals under baseline conditions. Together, the results suggest that reduced sympathetic activity is involved in the development of pain and muscle atrophy in the murine model of FM analyzed.</description><identifier>ISSN: 0031-9384</identifier><identifier>EISSN: 1873-507X</identifier><identifier>DOI: 10.1016/j.physbeh.2024.114575</identifier><identifier>PMID: 38692384</identifier><language>eng</language><publisher>United States: Elsevier Inc</publisher><subject>Adrenergic beta-Agonists - pharmacology ; Animals ; Carrageenan - toxicity ; Catecholamines - metabolism ; Clenbuterol - pharmacology ; Disease Models, Animal ; Epinephrine ; Female ; Fibromyalgia ; Fibromyalgia - pathology ; Fibromyalgia - physiopathology ; Hyperalgesia ; Hyperalgesia - pathology ; Hyperalgesia - physiopathology ; Muscle, Skeletal - drug effects ; Muscle, Skeletal - pathology ; Muscle, Skeletal - physiopathology ; Muscular Atrophy - pathology ; Muscular Atrophy - physiopathology ; Pain - pathology ; Pain - physiopathology ; Proteolysis ; Rats ; Rats, Sprague-Dawley ; Skeletal muscle ; Sympathetic nervous system ; Sympathetic Nervous System - drug effects ; Sympathetic Nervous System - pathology ; Sympathetic Nervous System - physiopathology</subject><ispartof>Physiology & behavior, 2024-07, Vol.281, p.114575-114575, Article 114575</ispartof><rights>2024 Elsevier Inc.</rights><rights>Copyright © 2024 Elsevier Inc. All rights reserved.</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><cites>FETCH-LOGICAL-c313t-f51e9de8b39f3d18366e486ed0ab8773ba49a13576405d2a678592136824d44e3</cites><orcidid>0000-0001-7118-743X</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://www.sciencedirect.com/science/article/pii/S0031938424001203$$EHTML$$P50$$Gelsevier$$H</linktohtml><link.rule.ids>314,776,780,3537,27901,27902,65306</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/38692384$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>da Silva, Raquel Prado</creatorcontrib><creatorcontrib>Costa, Daniely Messias</creatorcontrib><creatorcontrib>da Cruz-Filho, João</creatorcontrib><creatorcontrib>Santos, Tatiane de Oliveira</creatorcontrib><creatorcontrib>dos Anjos-Santos, Hevely Catharine</creatorcontrib><creatorcontrib>Vasconcelos, Alan Bruno Silva</creatorcontrib><creatorcontrib>Heck, Lilian Carmo</creatorcontrib><creatorcontrib>Kettelhut, Ísis do Carmo</creatorcontrib><creatorcontrib>Navegantes, Luiz Carlos</creatorcontrib><creatorcontrib>dos Santos, José Ronaldo</creatorcontrib><creatorcontrib>de Souza, Patrícia Rodrigues Marques</creatorcontrib><creatorcontrib>Badauê-Passos Jr, Daniel</creatorcontrib><creatorcontrib>Mecawi, André Souza</creatorcontrib><creatorcontrib>DeSantana, Josimari Melo</creatorcontrib><creatorcontrib>Lustrino, Danilo</creatorcontrib><title>Reduced sympathetic activity is associated with the development of pain and muscle atrophy in a female rat model of fibromyalgia</title><title>Physiology & behavior</title><addtitle>Physiol Behav</addtitle><description>•Plasma epinephrine is decreased in priming models of fibromyalgia-like pain.•Clenbuterol attenuates hyperalgesia in an acid saline-induced fibromyalgia-like pain model.•Clenbuterol mitigates muscle atrophy in fibromyalgia priming model.
Fibromyalgia (FM) is characterized by chronic widespread musculoskeletal pain accompanied by fatigue and muscle atrophy. Although its etiology is not known, studies have shown that FM patients exhibit altered function of the sympathetic nervous system (SNS), which regulates nociception and muscle plasticity. Nevertheless, the precise SNS-mediated mechanisms governing hyperalgesia and skeletal muscle atrophy in FM remain unclear. Thus, we employed two distinct FM-like pain models, involving intramuscular injections of acidic saline (pH 4.0) or carrageenan in prepubertal female rats, and evaluated the catecholamine content, adrenergic signaling and overall muscle proteolysis. Subsequently, we assessed the contribution of the SNS to the development of hyperalgesia and muscle atrophy in acidic saline-injected rats treated with clenbuterol (a selective β2-adrenergic receptor agonist) and in animals maintained under baseline conditions and subjected to epinephrine depletion through adrenodemedullation (ADM). Seven days after inducing an FM-like model with acidic saline or carrageenan, we observed widespread mechanical hyperalgesia along with loss of strength and/or muscle mass. These changes were associated with reduced catecholamine content, suggesting a common underlying mechanism. Notably, treatment with a β2-agonist alleviated hyperalgesia and prevented muscle atrophy in acidic saline-induced FM-like pain, while epinephrine depletion induced mechanical hyperalgesia and increased muscle proteolysis in animals under baseline conditions. Together, the results suggest that reduced sympathetic activity is involved in the development of pain and muscle atrophy in the murine model of FM analyzed.</description><subject>Adrenergic beta-Agonists - pharmacology</subject><subject>Animals</subject><subject>Carrageenan - toxicity</subject><subject>Catecholamines - metabolism</subject><subject>Clenbuterol - pharmacology</subject><subject>Disease Models, Animal</subject><subject>Epinephrine</subject><subject>Female</subject><subject>Fibromyalgia</subject><subject>Fibromyalgia - pathology</subject><subject>Fibromyalgia - physiopathology</subject><subject>Hyperalgesia</subject><subject>Hyperalgesia - pathology</subject><subject>Hyperalgesia - physiopathology</subject><subject>Muscle, Skeletal - drug effects</subject><subject>Muscle, Skeletal - pathology</subject><subject>Muscle, Skeletal - physiopathology</subject><subject>Muscular Atrophy - pathology</subject><subject>Muscular Atrophy - physiopathology</subject><subject>Pain - pathology</subject><subject>Pain - physiopathology</subject><subject>Proteolysis</subject><subject>Rats</subject><subject>Rats, Sprague-Dawley</subject><subject>Skeletal muscle</subject><subject>Sympathetic nervous system</subject><subject>Sympathetic Nervous System - drug effects</subject><subject>Sympathetic Nervous System - pathology</subject><subject>Sympathetic Nervous System - physiopathology</subject><issn>0031-9384</issn><issn>1873-507X</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2024</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNqFkE2v1CAUhonReMerP0HD0k1HKFDoypib60dyExOjiTtC4dRhUkoFOqY7f7pMZnQrG5I3z8s5PAi9pGRPCe3eHPfLYcsDHPYtafmeUi6keIR2VEnWCCK_P0Y7Qhhteqb4DXqW85HUwzh7im6Y6vq25jv0-wu41YLDeQuLKQco3mJjiz_5smGfsck5Wm9KRX75csAVwQ5OMMUlwFxwHPFi_IzN7HBYs50Am5JiXQ6fUzxCMDVLpuAQHUznwuiHFMNmph_ePEdPRjNleHG9b9G39_df7z42D58_fLp799BYRllpRkGhd6AG1o_MUcW6DrjqwBEzKCnZYHhvKBOy40S41nRSib6lrFMtd5wDu0WvL-8uKf5cIRcdfLYwTWaGuGbNiCBUtrJTFRUX1KaYc4JRL8kHkzZNiT7L10d9la_P8vVFfu29uo5YhwDuX-uv7Qq8vQBQP3rykHS2Huaq3yewRbvo_zPiD5qWmbI</recordid><startdate>20240701</startdate><enddate>20240701</enddate><creator>da Silva, Raquel Prado</creator><creator>Costa, Daniely Messias</creator><creator>da Cruz-Filho, João</creator><creator>Santos, Tatiane de Oliveira</creator><creator>dos Anjos-Santos, Hevely Catharine</creator><creator>Vasconcelos, Alan Bruno Silva</creator><creator>Heck, Lilian Carmo</creator><creator>Kettelhut, Ísis do Carmo</creator><creator>Navegantes, Luiz Carlos</creator><creator>dos Santos, José Ronaldo</creator><creator>de Souza, Patrícia Rodrigues Marques</creator><creator>Badauê-Passos Jr, Daniel</creator><creator>Mecawi, André Souza</creator><creator>DeSantana, Josimari Melo</creator><creator>Lustrino, Danilo</creator><general>Elsevier Inc</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope><orcidid>https://orcid.org/0000-0001-7118-743X</orcidid></search><sort><creationdate>20240701</creationdate><title>Reduced sympathetic activity is associated with the development of pain and muscle atrophy in a female rat model of fibromyalgia</title><author>da Silva, Raquel Prado ; Costa, Daniely Messias ; da Cruz-Filho, João ; Santos, Tatiane de Oliveira ; dos Anjos-Santos, Hevely Catharine ; Vasconcelos, Alan Bruno Silva ; Heck, Lilian Carmo ; Kettelhut, Ísis do Carmo ; Navegantes, Luiz Carlos ; dos Santos, José Ronaldo ; de Souza, Patrícia Rodrigues Marques ; Badauê-Passos Jr, Daniel ; Mecawi, André Souza ; DeSantana, Josimari Melo ; Lustrino, Danilo</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c313t-f51e9de8b39f3d18366e486ed0ab8773ba49a13576405d2a678592136824d44e3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2024</creationdate><topic>Adrenergic beta-Agonists - pharmacology</topic><topic>Animals</topic><topic>Carrageenan - toxicity</topic><topic>Catecholamines - metabolism</topic><topic>Clenbuterol - pharmacology</topic><topic>Disease Models, Animal</topic><topic>Epinephrine</topic><topic>Female</topic><topic>Fibromyalgia</topic><topic>Fibromyalgia - pathology</topic><topic>Fibromyalgia - physiopathology</topic><topic>Hyperalgesia</topic><topic>Hyperalgesia - pathology</topic><topic>Hyperalgesia - physiopathology</topic><topic>Muscle, Skeletal - drug effects</topic><topic>Muscle, Skeletal - pathology</topic><topic>Muscle, Skeletal - physiopathology</topic><topic>Muscular Atrophy - pathology</topic><topic>Muscular Atrophy - physiopathology</topic><topic>Pain - pathology</topic><topic>Pain - physiopathology</topic><topic>Proteolysis</topic><topic>Rats</topic><topic>Rats, Sprague-Dawley</topic><topic>Skeletal muscle</topic><topic>Sympathetic nervous system</topic><topic>Sympathetic Nervous System - drug effects</topic><topic>Sympathetic Nervous System - pathology</topic><topic>Sympathetic Nervous System - physiopathology</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>da Silva, Raquel Prado</creatorcontrib><creatorcontrib>Costa, Daniely Messias</creatorcontrib><creatorcontrib>da Cruz-Filho, João</creatorcontrib><creatorcontrib>Santos, Tatiane de Oliveira</creatorcontrib><creatorcontrib>dos Anjos-Santos, Hevely Catharine</creatorcontrib><creatorcontrib>Vasconcelos, Alan Bruno Silva</creatorcontrib><creatorcontrib>Heck, Lilian Carmo</creatorcontrib><creatorcontrib>Kettelhut, Ísis do Carmo</creatorcontrib><creatorcontrib>Navegantes, Luiz Carlos</creatorcontrib><creatorcontrib>dos Santos, José Ronaldo</creatorcontrib><creatorcontrib>de Souza, Patrícia Rodrigues Marques</creatorcontrib><creatorcontrib>Badauê-Passos Jr, Daniel</creatorcontrib><creatorcontrib>Mecawi, André Souza</creatorcontrib><creatorcontrib>DeSantana, Josimari Melo</creatorcontrib><creatorcontrib>Lustrino, Danilo</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>Physiology & behavior</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>da Silva, Raquel Prado</au><au>Costa, Daniely Messias</au><au>da Cruz-Filho, João</au><au>Santos, Tatiane de Oliveira</au><au>dos Anjos-Santos, Hevely Catharine</au><au>Vasconcelos, Alan Bruno Silva</au><au>Heck, Lilian Carmo</au><au>Kettelhut, Ísis do Carmo</au><au>Navegantes, Luiz Carlos</au><au>dos Santos, José Ronaldo</au><au>de Souza, Patrícia Rodrigues Marques</au><au>Badauê-Passos Jr, Daniel</au><au>Mecawi, André Souza</au><au>DeSantana, Josimari Melo</au><au>Lustrino, Danilo</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Reduced sympathetic activity is associated with the development of pain and muscle atrophy in a female rat model of fibromyalgia</atitle><jtitle>Physiology & behavior</jtitle><addtitle>Physiol Behav</addtitle><date>2024-07-01</date><risdate>2024</risdate><volume>281</volume><spage>114575</spage><epage>114575</epage><pages>114575-114575</pages><artnum>114575</artnum><issn>0031-9384</issn><eissn>1873-507X</eissn><abstract>•Plasma epinephrine is decreased in priming models of fibromyalgia-like pain.•Clenbuterol attenuates hyperalgesia in an acid saline-induced fibromyalgia-like pain model.•Clenbuterol mitigates muscle atrophy in fibromyalgia priming model.
Fibromyalgia (FM) is characterized by chronic widespread musculoskeletal pain accompanied by fatigue and muscle atrophy. Although its etiology is not known, studies have shown that FM patients exhibit altered function of the sympathetic nervous system (SNS), which regulates nociception and muscle plasticity. Nevertheless, the precise SNS-mediated mechanisms governing hyperalgesia and skeletal muscle atrophy in FM remain unclear. Thus, we employed two distinct FM-like pain models, involving intramuscular injections of acidic saline (pH 4.0) or carrageenan in prepubertal female rats, and evaluated the catecholamine content, adrenergic signaling and overall muscle proteolysis. Subsequently, we assessed the contribution of the SNS to the development of hyperalgesia and muscle atrophy in acidic saline-injected rats treated with clenbuterol (a selective β2-adrenergic receptor agonist) and in animals maintained under baseline conditions and subjected to epinephrine depletion through adrenodemedullation (ADM). Seven days after inducing an FM-like model with acidic saline or carrageenan, we observed widespread mechanical hyperalgesia along with loss of strength and/or muscle mass. These changes were associated with reduced catecholamine content, suggesting a common underlying mechanism. Notably, treatment with a β2-agonist alleviated hyperalgesia and prevented muscle atrophy in acidic saline-induced FM-like pain, while epinephrine depletion induced mechanical hyperalgesia and increased muscle proteolysis in animals under baseline conditions. Together, the results suggest that reduced sympathetic activity is involved in the development of pain and muscle atrophy in the murine model of FM analyzed.</abstract><cop>United States</cop><pub>Elsevier Inc</pub><pmid>38692384</pmid><doi>10.1016/j.physbeh.2024.114575</doi><tpages>1</tpages><orcidid>https://orcid.org/0000-0001-7118-743X</orcidid></addata></record> |
fulltext | fulltext |
identifier | ISSN: 0031-9384 |
ispartof | Physiology & behavior, 2024-07, Vol.281, p.114575-114575, Article 114575 |
issn | 0031-9384 1873-507X |
language | eng |
recordid | cdi_proquest_miscellaneous_3050172768 |
source | MEDLINE; Elsevier ScienceDirect Journals |
subjects | Adrenergic beta-Agonists - pharmacology Animals Carrageenan - toxicity Catecholamines - metabolism Clenbuterol - pharmacology Disease Models, Animal Epinephrine Female Fibromyalgia Fibromyalgia - pathology Fibromyalgia - physiopathology Hyperalgesia Hyperalgesia - pathology Hyperalgesia - physiopathology Muscle, Skeletal - drug effects Muscle, Skeletal - pathology Muscle, Skeletal - physiopathology Muscular Atrophy - pathology Muscular Atrophy - physiopathology Pain - pathology Pain - physiopathology Proteolysis Rats Rats, Sprague-Dawley Skeletal muscle Sympathetic nervous system Sympathetic Nervous System - drug effects Sympathetic Nervous System - pathology Sympathetic Nervous System - physiopathology |
title | Reduced sympathetic activity is associated with the development of pain and muscle atrophy in a female rat model of fibromyalgia |
url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-02T06%3A39%3A46IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Reduced%20sympathetic%20activity%20is%20associated%20with%20the%20development%20of%20pain%20and%20muscle%20atrophy%20in%20a%20female%20rat%20model%20of%20fibromyalgia&rft.jtitle=Physiology%20&%20behavior&rft.au=da%20Silva,%20Raquel%20Prado&rft.date=2024-07-01&rft.volume=281&rft.spage=114575&rft.epage=114575&rft.pages=114575-114575&rft.artnum=114575&rft.issn=0031-9384&rft.eissn=1873-507X&rft_id=info:doi/10.1016/j.physbeh.2024.114575&rft_dat=%3Cproquest_cross%3E3050172768%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=3050172768&rft_id=info:pmid/38692384&rft_els_id=S0031938424001203&rfr_iscdi=true |